Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in the Protective Effect of Brain Volume: Age Attenuates Protection in Women.

Stroke (Hoboken, N.J.)·2026
Same author

Retrospective longitudinal analysis of blood microRNA-7-5p as a possible progression biomarker in people with Parkinson's disease.

Frontiers in neuroscience·2026
Same author

Context-aware multi-property antibody predictor: a novel framework integrating text and protein language models.

NPJ systems biology and applications·2026
Same author

Defining Large Core Infarction: Comparing the Accuracy of Non-Contrast CT ASPECTS Versus CT Perfusion Core Volume.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2026
Same author

Machine Learning-Enabled Automated Large Vessel Occlusion Detection Improves Transfer Times at Primary Stroke Centers.

Stroke (Hoboken, N.J.)·2026
Same author

Machine Learning-Enabled Detection of Unruptured Cerebral Aneurysms Improves Detection Rates and Clinical Care.

Stroke (Hoboken, N.J.)·2026

Related Experiment Video

Updated: Jan 5, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K

Quantifying Neurodegenerative Progression With DeepSymNet, an End-to-End Data-Driven Approach.

Danilo Pena1,2, Arko Barman1,2, Jessika Suescun3

  • 1School of Biomedical Informatics, University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.

Frontiers in Neuroscience
|October 23, 2019
PubMed
Summary

A new deep learning method, DeepSymNet, tracks Alzheimer's disease (AD) progression using brain MRI. This AI approach identifies changes without predefined regions, offering faster, more accurate monitoring for early diagnosis and neurodegeneration tracking.

Keywords:
ADNIAlzheimer's diseasebiomarkersdeep learninglongitudinalmagnetic resonance imagingprogression

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Related Experiment Videos

Last Updated: Jan 5, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Neurodegenerative Diseases

Background:

  • Alzheimer's disease (AD) is a leading cause of death, with variable progression making monitoring challenging.
  • Current brain MRI analysis for AD relies on complex, time-consuming methods prone to errors.
  • Existing techniques require predefined regions of interest and non-linear registration, hindering clinical translation.

Purpose of the Study:

  • To develop a novel, data-driven deep learning method for quantifying longitudinal changes in Alzheimer's disease.
  • To overcome limitations of current neuroimaging analysis pipelines in AD progression monitoring.
  • To create a more efficient and accurate tool for early AD diagnosis and patient assessment.

Main Methods:

  • An extended deep learning architecture, DeepSymNet, was developed for end-to-end training.
  • The model analyzes longitudinal brain MRI data directly from raw voxels, avoiding atlases and non-linear registration.
  • Performance was validated against Freesurfer longitudinal pipelines and voxel-based methods using the ADNI database.

Main Results:

  • DeepSymNet achieved comparable results to Freesurfer longitudinal pipelines in identifying AD progression, but with significantly reduced processing time.
  • The model demonstrated statistically significant performance improvements over other voxel-based methods.
  • DeepSymNet successfully differentiated between healthy subjects and those with mild cognitive impairment (MCI).

Conclusions:

  • The proposed deep learning approach offers a powerful, efficient method for monitoring neurodegeneration in Alzheimer's disease.
  • DeepSymNet's ability to analyze longitudinal changes without prior assumptions has the potential to enhance early diagnosis and clinical practice.
  • Model interpretability revealed key brain regions (pallidum, putamen, superior temporal gyrus) driving predictions, offering insights into AD pathology.